PRMT5 and lip and oral cavity carcinoma: We speculate that these cells gain growth and survival advantage against IR treatment to affect the outcome of the radiotherapy significantly, as high expression levels of PRMT5 and APE1 have been associated with poor outcomes of radiation therapy in oral cancer patients.